These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 24029705

  • 1. Immunohistochemical analysis of chromogranin A and p53 expressions in ulcerative colitis-associated neoplasia: neuroendocrine differentiation as an early event in the colitis-neoplasia sequence.
    Shigaki K, Mitomi H, Fujimori T, Ichikawa K, Tomita S, Imura J, Fujii S, Itabashi M, Kameoka S, Sahara R, Takenoshita S.
    Hum Pathol; 2013 Nov; 44(11):2393-9. PubMed ID: 24029705
    [Abstract] [Full Text] [Related]

  • 2. p53 immunohistochemistry of ulcerative colitis-associated with dysplasia and carcinoma.
    Sato A, MacHinami R.
    Pathol Int; 1999 Oct; 49(10):858-68. PubMed ID: 10571818
    [Abstract] [Full Text] [Related]

  • 3. Usefulness of analysis of p53 alteration and observation of surface microstructure for diagnosis of ulcerative colitis-associated colorectal neoplasia.
    Fujii S, Fujimori T, Chiba T.
    J Exp Clin Cancer Res; 2003 Mar; 22(1):107-15. PubMed ID: 12725330
    [Abstract] [Full Text] [Related]

  • 4. Role of immunohistochemical markers in predicting progression of dysplasia to advanced neoplasia in patients with ulcerative colitis.
    van Schaik FD, Oldenburg B, Offerhaus GJ, Schipper ME, Vleggaar FP, Siersema PD, van Oijen MG, Ten Kate FJ.
    Inflamm Bowel Dis; 2012 Mar; 18(3):480-8. PubMed ID: 21509910
    [Abstract] [Full Text] [Related]

  • 5. Apoptosis regulation differs between ulcerative colitis-associated and sporadic colonic tumors. Association with survivin and bcl-2.
    Mikami T, Yoshida T, Akino F, Motoori T, Yajima M, Okayasu I.
    Am J Clin Pathol; 2003 May; 119(5):723-30. PubMed ID: 12760292
    [Abstract] [Full Text] [Related]

  • 6. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease.
    Dorer R, Odze RD.
    Am J Surg Pathol; 2006 Jul; 30(7):871-7. PubMed ID: 16819330
    [Abstract] [Full Text] [Related]

  • 7. Expression of activation-induced cytidine deaminase in ulcerative colitis-associated carcinogenesis.
    Gushima M, Hirahashi M, Matsumoto T, Fujita K, Ohuchida K, Oda Y, Yao T, Iida M, Tsuneyoshi M.
    Histopathology; 2011 Sep; 59(3):460-9. PubMed ID: 22034886
    [Abstract] [Full Text] [Related]

  • 8. Immunohistochemical assessment of a unique basal pattern of p53 expression in ulcerative-colitis-associated neoplasia using computer-assisted cytometry.
    Kobayashi S, Fujimori T, Mitomi H, Tomita S, Ichikawa K, Imura J, Fujii S, Itabashi M, Kameoka S, Igarashi Y.
    Diagn Pathol; 2014 May 29; 9():99. PubMed ID: 24886509
    [Abstract] [Full Text] [Related]

  • 9. [Immunohistochemical distribution of p53 and Ki-67 in 2 cases of colorectal carcinoma occurring in ulcerative colitis].
    Maruyama K, Saigusa N, Baba S, Kino I.
    Gan To Kagaku Ryoho; 1995 Jun 29; 22 Suppl 2():145-8. PubMed ID: 7611778
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemical analysis of REG Iα expression in ulcerative colitis-associated neoplastic lesions.
    Tanaka H, Fukui H, Fujii S, Sekikawa A, Yamagishi H, Ichikawa K, Tomita S, Imura J, Yasuda Y, Chiba T, Fujimori T.
    Digestion; 2011 Jun 29; 83(3):204-9. PubMed ID: 21266817
    [Abstract] [Full Text] [Related]

  • 11. Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia.
    Hanaoka M, Ishikawa T, Ishiguro M, Tokura M, Yamauchi S, Kikuchi A, Uetake H, Yasuno M, Kawano T.
    J Gastroenterol; 2018 May 29; 53(5):631-641. PubMed ID: 28884228
    [Abstract] [Full Text] [Related]

  • 12. Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance.
    Navaneethan U, Jegadeesan R, Gutierrez NG, Venkatesh PG, Hammel JP, Shen B, Kiran RP.
    J Crohns Colitis; 2013 Dec 29; 7(12):e684-91. PubMed ID: 23916526
    [Abstract] [Full Text] [Related]

  • 13. Immunohistochemical expression of P53 and oncogenes in ulcerative colitis-associated colorectal carcinoma.
    Brüwer M, Schmid KW, Senninger N, Schürmann G.
    World J Surg; 2002 Mar 29; 26(3):390-6. PubMed ID: 11865380
    [Abstract] [Full Text] [Related]

  • 14. An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63.
    McCluggage WG, Kennedy K, Busam KJ.
    Am J Surg Pathol; 2010 Apr 29; 34(4):525-32. PubMed ID: 20182342
    [Abstract] [Full Text] [Related]

  • 15. Immunohistochemistry in the diagnosis of dysplasia in chronic inflammatory bowel disease colorectal polyps.
    B Brahim E, Mrabet A, Jouini R, Koubaa W, B Sidhom R, Elloumi H, Chadli A.
    Arab J Gastroenterol; 2016 Sep 29; 17(3):121-126. PubMed ID: 27567189
    [Abstract] [Full Text] [Related]

  • 16. Wnt pathway-related gene expression during malignant progression in ulcerative colitis.
    van Dekken H, Wink JC, Vissers KJ, Franken PF, Ruud Schouten W, J Hop WC, Kuipers EJ, Fodde R, Janneke van der Woude C.
    Acta Histochem; 2007 Sep 29; 109(4):266-72. PubMed ID: 17445872
    [Abstract] [Full Text] [Related]

  • 17. [Overexpressed p53 protein and cell-proliferative activity disappear or remarkably decrease in neoplastic CGA-positive endocrine and Paneth cells in cancer or dysplasia of ulcerative colitis].
    Matsuda K, Watanabe H, Ohta T, Ajioka Y.
    Nihon Shokakibyo Gakkai Zasshi; 1995 Dec 29; 92(12):1922-8. PubMed ID: 8558776
    [Abstract] [Full Text] [Related]

  • 18. Identification of patients with developing ulcerative colitis-associated neoplasia by nitrative DNA damage marker 8-nitroguanin expression in rectal mucosa.
    Saigusa S, Araki T, Tanaka K, Hashimoto K, Okita Y, Fujikawa H, Okugawa Y, Toiyama Y, Inoue Y, Uchida K, Mohri Y, Kusunoki M.
    J Clin Gastroenterol; 2013 Oct 29; 47(9):e80-6. PubMed ID: 23632356
    [Abstract] [Full Text] [Related]

  • 19. Disruption of the p53-p53r2 DNA repair system in ulcerative colitis contributes to colon tumorigenesis.
    Yoshida T, Haga S, Numata Y, Yamashita K, Mikami T, Ogawa T, Ohkusa T, Okayasu I.
    Int J Cancer; 2006 Mar 15; 118(6):1395-403. PubMed ID: 16206288
    [Abstract] [Full Text] [Related]

  • 20. Ki-67 and ProExC are useful immunohistochemical markers in esophageal squamous intraepithelial neoplasia.
    Wang WC, Wu TT, Chandan VS, Lohse CM, Zhang L.
    Hum Pathol; 2011 Oct 15; 42(10):1430-7. PubMed ID: 21420715
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.